Skip to main content
placeholder image

RAINBOW: A global, phase 3, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) plus PTX in the treatment of advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy���An age-group analysis.

Journal Article


Abstract


UOW Authors


  •   Clingan, Phillip (external author)

Publication Date


  • 2015

Citation


  • Muro, K., Bodoky, G., Cesas, A., Chao, Y., Clingan, P., Hironaka, S., . . . Wilke, H. (2015). RAINBOW: A global, phase 3, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) plus PTX in the treatment of advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy���An age-group analysis.. Journal of Clinical Oncology, 33(3_suppl), 11. doi:10.1200/jco.2015.33.3_suppl.11

Web Of Science Accession Number


Start Page


  • 11

End Page


  • 11

Volume


  • 33

Issue


  • 3_suppl

Place Of Publication


Abstract


UOW Authors


  •   Clingan, Phillip (external author)

Publication Date


  • 2015

Citation


  • Muro, K., Bodoky, G., Cesas, A., Chao, Y., Clingan, P., Hironaka, S., . . . Wilke, H. (2015). RAINBOW: A global, phase 3, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) plus PTX in the treatment of advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy���An age-group analysis.. Journal of Clinical Oncology, 33(3_suppl), 11. doi:10.1200/jco.2015.33.3_suppl.11

Web Of Science Accession Number


Start Page


  • 11

End Page


  • 11

Volume


  • 33

Issue


  • 3_suppl

Place Of Publication